Endocrine System Medical Terminology: A Complete Reference for Healthcare Workers
A complete reference guide to endocrine system medical terminology for healthcare workers, covering glands and hormones, diabetes terminology, thyroid conditions, and key abbreviations used in Australian clinical settings.
Post Author:
TalentMed

The endocrine system generates some of the densest clinical documentation in Australian healthcare. A single hospital discharge summary for a patient admitted with diabetic ketoacidosis can contain a dozen abbreviations, four separate investigation result sets, and references to three or four specific complications, each with its own ICD-10-AM code implications. For anyone working with patient records (clinical coders, medical transcriptionists, or practice administrators), a solid working vocabulary of endocrine terminology is not optional. It is the foundation of accurate, compliant work.
This reference article covers the complete endocrine vocabulary you are likely to encounter in Australian clinical settings: the glands and their hormones, diabetes mellitus terminology, thyroid and other endocrine conditions, common investigations and procedures, and an abbreviations quick-reference table. It is written for healthcare support workers and students enrolled in, or considering, BSBMED301 Interpret and Apply Medical Terminology Appropriately, the nationally recognised unit delivered online by TalentMed (RTO 22151).
Why endocrine terminology matters in healthcare
Diabetes alone accounts for more than one in ten general practice consultations in Australia. Thyroid disorders affect approximately one in twenty adults, with hypothyroidism particularly prevalent among women over 40. Polycystic ovary syndrome affects around one in eight women of reproductive age. Taken together, endocrine conditions represent a large and growing proportion of the clinical workload in both primary care and hospital settings.
For clinical coders, endocrine terminology directly affects code selection and DRG assignment. Misreading “HHS” as “HbA1c” or confusing diabetic neuropathy with diabetic nephropathy produces incorrect codes with downstream funding consequences. The Australian Coding Standards require coders to link diabetes codes with their specific complication codes, so understanding which complication is documented is essential. See the TalentMed spoke on coding diabetes complications for the ICD-10-AM classification detail.
For medical transcriptionists, endocrine terminology presents particular challenges because many terms are phonetically similar but clinically distinct. “Hyperglycaemia” and “hypoglycaemia” differ by a single three-letter component but describe opposite states with opposite clinical urgency. “Hypo” in a discharge summary is a colloquial shorthand for hypoglycaemia. A transcriptionist who renders it as “hypothyroidism” has introduced a clinically significant error.
For practice administrators, endocrine terminology appears in referral letters, investigation request forms, recall systems, and billing records. Understanding what “fasting bloods for HbA1c and TFTs” means, and routing the results and follow-up reminders correctly, requires familiarity with the terms, even without clinical depth.
The medical terminology hub at TalentMed builds this foundation systematically. The body-system-by-system approach used in this article series allows you to focus on the terminology most relevant to your current work, then expand outward. If you have not yet read the overview, the medical terms by body system article is the natural starting point for contextualising where the endocrine system sits within the broader anatomy.
The endocrine system: glands and hormones
The endocrine system is a network of glands and organs that communicate through chemical messengers called hormones. The prefix “endo-” means within; “krinein” (Greek) means to secrete. Endocrine glands secrete directly into the bloodstream, in contrast to exocrine glands, which secrete through ducts (salivary glands, sweat glands, digestive enzymes). This distinction matters when reading pathology reports, where “endocrine tumour” and “exocrine tumour” of the pancreas, for example, refer to entirely different cell types with different prognoses.
Hormones are categorised by their chemical structure: steroid hormones (derived from cholesterol, including cortisol and oestrogen), peptide/protein hormones (including insulin, TSH, and GH), and amine hormones (including adrenaline and thyroid hormones). This categorisation affects how they are synthesised, stored, transported, and how quickly they act. All of these details appear in specialist endocrinology correspondence.
The table below covers all major endocrine glands, their primary hormones, and the function of each. When you encounter a term like “ACTH stimulation test” or “TSH elevation”, you can use this table to trace the physiological logic: which gland is being assessed, what hormone it produces, and what that hormone normally does.
| Gland | Hormones produced | Primary function |
|---|---|---|
| Hypothalamus | CRH, TRH, GHRH, GnRH, ADH (vasopressin), oxytocin | Regulates pituitary output; controls water balance; stimulates uterine contractions via oxytocin |
| Anterior pituitary (adenohypophysis) | ACTH, TSH, FSH, LH, GH, prolactin | Controls adrenals, thyroid, gonads, growth, and lactation via trophic hormones |
| Posterior pituitary (neurohypophysis) | ADH (vasopressin), oxytocin (stored and released here) | Controls renal water reabsorption; stimulates uterine contraction and let-down reflex |
| Thyroid gland | T3 (triiodothyronine), T4 (thyroxine), calcitonin | Regulates metabolic rate, growth, and development; lowers serum calcium via calcitonin |
| Parathyroid glands (4 small glands posterior to thyroid) | PTH (parathyroid hormone) | Raises serum calcium by stimulating bone resorption and renal calcium reabsorption |
| Adrenal cortex | Cortisol, aldosterone, androgens (DHEA) | Stress response (cortisol); sodium and water balance (aldosterone); secondary sex characteristics |
| Adrenal medulla | Adrenaline (epinephrine), noradrenaline (norepinephrine) | Fight-or-flight response: raises heart rate, blood pressure, and blood glucose acutely |
| Pancreas (islets of Langerhans) | Insulin (beta cells), glucagon (alpha cells), somatostatin (delta cells) | Regulates blood glucose: insulin lowers it, glucagon raises it; somatostatin inhibits both |
| Ovaries | Oestrogen, progesterone | Female reproductive cycle, secondary sex characteristics, bone density maintenance |
| Testes | Testosterone | Male reproductive function, sperm production, secondary sex characteristics |
| Pineal gland | Melatonin | Circadian rhythm regulation and sleep-wake cycle coordination |
| Thymus | Thymosin, thymopoietin | Immune system development; T-cell maturation (most active during childhood) |
Two concepts that appear throughout endocrinology documentation are worth understanding. Negative feedback describes the mechanism by which elevated hormone levels suppress further secretion (the same principle as a thermostat). Trophic hormones are pituitary hormones that stimulate another gland (TSH stimulates the thyroid; ACTH stimulates the adrenal cortex). When you see “TSH suppressed” on a TFT result, that means the pituitary is reducing output because thyroid hormone levels are already high.
Diabetes mellitus terminology
Diabetes mellitus is Australia’s fastest-growing chronic disease and one of the most common reasons for hospital admission as a comorbidity. The term “mellitus” (Latin: honey-sweet) distinguishes this condition from diabetes insipidus, which involves water rather than glucose regulation and is covered later in this article.
For clinical coders, the distinction between diabetes types and their associated complications is critical. ICD-10-AM assigns specific code combinations for diabetes with nephropathy, neuropathy, retinopathy, and other complications. Using a non-specific diabetes code when a complication is clearly documented in the record is an error that affects AR-DRG assignment. The TalentMed article on coding comorbidities and additional diagnoses addresses the framework for additional diagnosis coding that applies when diabetes is a secondary condition.
The table below covers the key diabetes terminology encountered in Australian clinical records, including types, investigations, and complications.
| Term | Definition | Clinical context |
|---|---|---|
| Type 1 diabetes mellitus (T1DM) | Autoimmune destruction of pancreatic beta cells; requires exogenous insulin for survival | Usually presents in childhood or early adulthood; formerly called IDDM (insulin-dependent DM) |
| Type 2 diabetes mellitus (T2DM) | Insulin resistance combined with progressive beta-cell dysfunction and relative insulin deficiency | Accounts for 85 to 90% of Australian diabetes cases; managed with lifestyle, oral agents, and/or insulin |
| Gestational diabetes mellitus (GDM) | Glucose intolerance first recognised during pregnancy; diagnosed via OGTT at 24 to 28 weeks | Resolves after delivery in most cases but raises lifetime T2DM risk for both mother and child |
| MODY (maturity-onset diabetes of the young) | Monogenic diabetes from single-gene mutations affecting beta-cell function | Often misclassified as T1DM or T2DM; strong family history; some subtypes respond to sulphonylureas |
| HbA1c (glycated haemoglobin) | Measures average blood glucose over 8 to 12 weeks; reported as percentage and mmol/mol in Australia | Gold standard for glycaemic monitoring; HbA1c ≥48 mmol/mol (6.5%) meets diagnostic threshold for DM |
| OGTT (oral glucose tolerance test) | Fasting glucose measured, then blood glucose 2 hours after a 75g oral glucose load | Used to diagnose GDM and impaired glucose tolerance; also applied in borderline T2DM diagnosis |
| Hyperglycaemia | Elevated blood glucose above normal (fasting ≥7.0 mmol/L; random ≥11.1 mmol/L) | Key sign in uncontrolled diabetes; drives long-term vascular, renal, and neurological complications |
| Hypoglycaemia | Low blood glucose (typically below 4.0 mmol/L); colloquially “a hypo” | Common in insulin-treated patients; acute risk of unconsciousness; managed with glucose or glucagon |
| Insulin resistance | Reduced cellular response to insulin, requiring higher insulin levels to maintain normal glucose | Central mechanism in T2DM; also a feature of PCOS, metabolic syndrome, and obesity |
| Diabetic ketoacidosis (DKA) | Severe insulin deficiency leading to ketone accumulation and metabolic acidosis; life-threatening | Primarily T1DM; triggers: missed insulin, infection, illness; presents with vomiting, fruity breath, abdominal pain |
| Hyperosmolar hyperglycaemic state (HHS) | Severe T2DM hyperglycaemia without significant ketoacidosis; extreme dehydration | Higher mortality than DKA; triggers: infection, dehydration, medication non-compliance |
| Diabetic neuropathy | Nerve damage from prolonged hyperglycaemia; peripheral (sensory loss, feet) or autonomic (gastroparesis) | Common long-term complication; peripheral neuropathy raises amputation risk; ICD-10-AM has specific complication codes |
| Diabetic nephropathy | Progressive kidney damage from diabetes; starts with microalbuminuria, advances to CKD | Leading cause of end-stage kidney disease in Australia; complicates coding when both DM and CKD are documented |
| Diabetic retinopathy | Retinal microvascular damage from chronic hyperglycaemia; can cause blindness if untreated | Leading preventable cause of blindness in working-age Australians; routinely screened via ophthalmology referral |
Thyroid and other endocrine conditions
The thyroid gland sits in the anterior neck and produces hormones that set the body’s metabolic rate. “Thyro-” (from the Greek “thyreos”, meaning shield, which describes the gland’s shape) is the prefix you will see throughout thyroid-related documentation. Conditions such as hypothyroidism and hyperthyroidism appear in roughly five per cent of the Australian adult population, making thyroid function tests (TFTs) among the most commonly ordered blood panels in general practice.
The parathyroid glands (four small glands embedded in the posterior thyroid) are often caught in the surgical field during thyroidectomy, which is why post-thyroidectomy hypoparathyroidism and hypocalcaemia are recognised complications that clinical coders need to know about.
Beyond the thyroid, the adrenal glands, pituitary gland, and pancreas contribute a range of less common but clinically significant conditions. The table below consolidates the terminology for all of these into a single reference.
| Condition | Key terms and description | Common abbreviations |
|---|---|---|
| Hypothyroidism | Underactive thyroid; reduced T3/T4 production; elevated TSH on TFTs; treated with levothyroxine (thyroxine replacement); symptoms include fatigue, weight gain, cold intolerance | TFTs, TSH, T4, T3 |
| Hyperthyroidism | Overactive thyroid; excess T3/T4; suppressed TSH; symptoms include tachycardia, weight loss, heat intolerance, tremor, and anxiety | TFTs, TSH, fT4, fT3 |
| Graves’ disease | Autoimmune hyperthyroidism; TSH receptor antibodies (TRAb) stimulate the thyroid continuously; associated with exophthalmos (eye protrusion) and pretibial myxoedema | TRAb, TFTs, exophthalmos |
| Hashimoto’s thyroiditis | Autoimmune hypothyroidism; thyroid peroxidase antibodies (TPOAb) cause gradual glandular destruction; most common cause of hypothyroidism in Australia | TPOAb, TFTs, TSH |
| Goitre | Enlargement of the thyroid gland; can be simple, multinodular, or associated with hyper- or hypothyroidism; assessed by ultrasound | USS (ultrasound) |
| Thyroid nodule / thyroid cancer | Nodules assessed by fine-needle aspiration cytology (FNAC); Bethesda System I to VI classification; papillary, follicular, medullary, and anaplastic thyroid carcinoma are the main types | FNAC, FNA, USS, Bethesda |
| Thyroidectomy | Surgical removal: hemithyroidectomy (one lobe) or total thyroidectomy (whole gland); lifelong thyroxine replacement required after total thyroidectomy | TT (total thyroidectomy), HT (hemithyroidectomy) |
| Thyrotoxic crisis (thyroid storm) | Life-threatening exacerbation of hyperthyroidism; features include high fever, tachyarrhythmia, and altered consciousness; ICU-level care required | TFTs, ICU |
| Cushing’s syndrome | Excess cortisol from any cause; features include central obesity, hypertension, purple striae, easy bruising, and glucose intolerance; pituitary-driven form is Cushing’s disease | ACTH, UFC (urinary free cortisol), DST (dexamethasone suppression test) |
| Addison’s disease (primary adrenal insufficiency) | Insufficient cortisol and aldosterone from adrenal destruction; autoimmune in most Australian cases; Addisonian crisis is life-threatening under physiological stress | SST (short Synacthen test), ACTH |
| PCOS (polycystic ovary syndrome) | Common endocrine disorder in women; irregular cycles, androgen excess, and polycystic ovaries on ultrasound; associated with insulin resistance and T2DM risk | PCOS, LH, FSH, DHEAS, AMH |
| Acromegaly | Excess growth hormone in adults, usually from a pituitary adenoma; causes enlargement of facial features, hands, and feet; diagnosed by elevated IGF-1 | GH, IGF-1, MRI pituitary |
| Diabetes insipidus (DI) | Not diabetes mellitus: central DI from insufficient ADH, or nephrogenic DI from renal ADH resistance; causes extreme thirst and large volumes of dilute urine | DI, ADH, serum/urine osmolality |
| SIADH | Syndrome of inappropriate ADH secretion: excess ADH causes water retention and dilutional hyponatraemia; associated with CNS disorders, lung malignancy, and certain medications | SIADH, Na, serum/urine osmolality |
A point worth noting for transcriptionists and coders: diabetes insipidus and diabetes mellitus share only the word “diabetes” (from the Greek for “siphon”, referring to the excessive urination both conditions cause). They involve entirely different organ systems, different mechanisms, and different ICD-10-AM code ranges. In clinical documentation, the type will always be specified. Never abbreviate either as simply “DM” when the context could be ambiguous.
Endocrine procedures and investigations
Endocrinology generates a broad range of investigations. Clinical coders need to accurately identify which procedures were performed to assign the correct ACHI codes. Transcriptionists need to spell these terms correctly in letters and reports. Practice administrators manage referrals and results for them. The following are the most frequently encountered investigations in Australian hospital and general practice settings.
- Thyroid function tests (TFTs): A blood panel measuring TSH, free T4, and sometimes free T3. TSH is the most sensitive single marker for thyroid disease. An elevated TSH with low fT4 confirms hypothyroidism; a suppressed TSH with elevated fT4 confirms hyperthyroidism.
- HbA1c: No fasting required. Reported in both percentage and mmol/mol in current Australian pathology. A result of 48 mmol/mol (6.5%) or above meets the diagnostic threshold for diabetes when confirmed on a second test.
- Oral glucose tolerance test (OGTT): Fasting glucose taken, then blood glucose 2 hours after a 75g oral glucose load. Key for diagnosing GDM and impaired glucose tolerance.
- Synacthen (ACTH stimulation) test: Synthetic ACTH is injected and serum cortisol measured at baseline and 30 to 60 minutes after. Used to confirm or exclude adrenal insufficiency (Addison’s disease).
- Dexamethasone suppression test (DST): Overnight or 48-hour protocol to screen for Cushing’s syndrome. Dexamethasone suppresses cortisol in normal individuals but not in Cushing’s. The low-dose and high-dose versions distinguish Cushing’s disease (pituitary) from ectopic ACTH production.
- Fine-needle aspiration cytology (FNAC) of the thyroid: A thin needle extracts cells from a thyroid nodule under ultrasound guidance. Results are classified using the Bethesda System (Category I to VI, from non-diagnostic to malignant).
- MRI pituitary: Magnetic resonance imaging of the pituitary fossa; identifies pituitary adenomas in conditions such as Cushing’s disease, acromegaly, and prolactinoma. Also written as “MRI brain with pituitary protocol”.
- Insulin tolerance test (ITT): Assesses growth hormone reserve and hypothalamic-pituitary-adrenal axis integrity by inducing hypoglycaemia under controlled conditions. Requires specialist supervision due to the hypoglycaemia risk.
Familiarity with prefix and suffix patterns makes procedure names much easier to decode. The suffix “-ectomy” (surgical removal), “-scopy” (to look/examine), and “-oma” (tumour or mass) apply across endocrine procedures just as they do in other body systems. For a systematic approach to breaking down medical terms, the TalentMed article on common medical prefixes and suffixes is a practical companion to this reference.
Abbreviations quick-reference
Endocrine documentation is abbreviation-dense. The table below covers the most frequently used abbreviations in Australian clinical settings, with their full forms and a contextual note. For the complete cross-system reference, see common medical abbreviations in Australian healthcare.
| Abbreviation | Full form | Usage note |
|---|---|---|
| DM | Diabetes mellitus | Generic; always qualified (T1DM, T2DM, GDM) in clinical coding to avoid ambiguity with other uses |
| T1DM | Type 1 diabetes mellitus | Replaces older “IDDM” (insulin-dependent DM); preferred in current Australian documentation |
| T2DM | Type 2 diabetes mellitus | Replaces older “NIDDM” (non-insulin-dependent DM); most prevalent form of diabetes in Australia |
| GDM | Gestational diabetes mellitus | Diagnosed in pregnancy; ICD-10-AM codes in O24.4 range; specify if pre-existing or new-onset |
| HbA1c | Glycated haemoglobin (haemoglobin A1c) | Dual reporting (percentage and mmol/mol) is standard in Australia; monitors long-term glycaemic control |
| OGTT | Oral glucose tolerance test | Used for GDM screening (24 to 28 weeks gestation) and T2DM diagnosis in borderline cases |
| TSH | Thyroid-stimulating hormone | Most sensitive marker for thyroid disease; elevated in hypothyroidism, suppressed in hyperthyroidism |
| T3 | Triiodothyronine | The biologically active thyroid hormone; measured as free T3 (fT3) in blood tests |
| T4 | Thyroxine | Main secretory product of the thyroid; measured as free T4 (fT4); converted to T3 in peripheral tissues |
| TFTs | Thyroid function tests | Blood panel including TSH, fT4, and sometimes fT3; ordered as a group on pathology request forms |
| PCOS | Polycystic ovary syndrome | Common in women of reproductive age; intersects endocrine, gynaecology, and fertility medicine |
| ACTH | Adrenocorticotrophic hormone | Pituitary hormone stimulating cortisol production; used in Synacthen test and Cushing’s workup |
| SIADH | Syndrome of inappropriate antidiuretic hormone secretion | Causes dilutional hyponatraemia; linked to CNS injury, pulmonary disease, malignancy, and medications |
| DKA | Diabetic ketoacidosis | Life-threatening T1DM complication (occasionally T2DM); requires urgent hospital admission |
| HHS | Hyperosmolar hyperglycaemic state | Severe T2DM complication with high glucose but minimal ketosis; higher mortality than DKA |
| GH | Growth hormone | Excess in adults causes acromegaly; deficiency causes adult GH deficiency syndrome |
| IGF-1 | Insulin-like growth factor 1 | Mediates GH effects; elevated in acromegaly; used as screening and monitoring marker |
| FNAC | Fine-needle aspiration cytology | Assessment tool for thyroid nodules; also written as FNA (fine-needle aspiration) |
| ADH | Antidiuretic hormone (vasopressin) | Controls renal water reabsorption; deficiency causes diabetes insipidus; excess causes SIADH |
| PTH | Parathyroid hormone | Raises serum calcium; elevated in hyperparathyroidism; may fall post-thyroidectomy if parathyroids are disturbed |
A note on safe abbreviation practice: while abbreviations are standard in clinical documentation, some carry misinterpretation risk. “DI” could mean diabetes insipidus or a different abbreviation in another specialty context. Unambiguous documentation always qualifies abbreviations on first use. For a guide to the abbreviations that Australian health services recommend avoiding in handwritten or spoken orders, see dangerous medical abbreviations: the do-not-use list.
Frequently asked questions
On this page
BSBMED301
Interpret and Apply Medical Terminology Appropriately
- ✓ 100% online, self-paced
- ✓ Entry-level healthcare vocabulary
- ✓ Nationally recognised unit
- ✓ Delivered by TalentMed RTO 22151
Book a call
Speak to a TalentMed course adviser about BSBMED301 and your healthcare study options.
Medical terminology news
Build your medical vocabulary. Monthly tips, terms, and career starter resources.
Want to find out more?
Enter your details below to receive a free information pack instantly.




